Irbezyd 150/Irbezyd 300

Irbezyd 150/Irbezyd 300

irbesartan

Manufacturer:

Cadila Healthcare

Distributor:

Metro Drug

Marketer:

Zydus Healthcare Phils
Concise Prescribing Info
Contents
Irbesartan
Indications/Uses
Treatment of HTN & renal disease in hypertensive type 2 DM.
Dosage/Direction for Use
Initially 150 mg once daily. Increased if necessary to 300 mg once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Dehydration, CHF. Pregnancy & lactation.
Special Precautions
Acute hypotension, azotemia, oliguria or rarely acute renal failure in patients w/ severe CHF or underlying renal disease including renal artery stenosis. Excessive BP decrease resulting to MI or stroke in patients w/ ischemic cardiopathy or ischemic CV disease. Less effective in lowering BP in Black patients. Intravascular vol depletion. Renovascular HTN. Renal impairment & kidney transplantation. Hyperkalemia. Primary aldosteronism. Childn.
Adverse Reactions
Dizziness, nausea, vomiting, fatigue, orthostatic dizziness, orthostatic hypotension, musculoskeletal pain, arthralgia, myalgia, muscle cramps. Tachycardia, cough, diarrhea, dyspepsia, heartburn, sexual dysfunction, chest pain, flushing.
Drug Interactions
May increase serum K levels w/ K supplements & K-sparing diuretics. Increased serum conc of lithium. May lead to an increased risk of worsening of renal function w/ NSAIDs.
ATC Classification
C09CA04 - irbesartan ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Irbezyd 150 film-coated tab 150 mg
Packing/Price
100's (P1,571.43/box, P15.71/film-coated tab)
Form
Irbezyd 300 film-coated tab 300 mg
Packing/Price
100's (P25.54/film-coated tab, P2,553.57/box)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in